Covaxin gets emergency use approval in the 2-18 age group
Bharat Biotech's antidote will be the second vaccine for children after Zydus' ZyCov-D12-10-2021
Covaxin gets emergency use approval in the 2-18 age group
Bharat Biotech's antidote will be the second vaccine for children after Zydus' ZyCov-DZydus Wellness Ltd - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Compliance under Regulation 39(3) of Details of Loss of Certificate.ZYDUS WELLNESS LTD.-$ - 531335 - Shareholding for the Period Ended September 30, 2021
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click hereZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance Intimation under Regulation 39(3) for details of loss of share certificate.Zydus Wellness Ltd - 531335 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhanraj P DagarDesignation :- Company Secretary and Compliance OfficerZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.DCGI approves Phase 3 trial of Zydus' two-dose vaccine
The development comes in the backdrop of Zydus presenting a revised clinical trial protocolZydus' antibody cocktail, Glenmark's nasal spray among 20 drugs in the pipeline to fight COVID-19
While the market for these drugs may not be huge at present due to a drop in Covid-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity.Zydus Wellness Ltd - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of details of loss of certificate under regulation 39(3) of LODR.3-dose Zydus vaccine to be included in Covid vaccination programme: Govt
Sixty-nine per cent of the country's adult population has received at least one dose of Covid-19 vaccine and 25% has taken both doses, the government said on Thursday.